THE RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 9116
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
 
 
C07K PEPTIDES 5131
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
 
 
H05B ELECTRIC HEATING; ELECTRIC LIGHTING NOT OTHERWISE PROVIDED FOR 1110

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0244,805 METHODS FOR SCREENING TO IDENTIFY THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND USE THEREOFFeb 22, 16Aug 25, 16[A61K, C12Q]
2016/0022,714 O-GLCNACYLATION TREATMENT FOR ISCHEMIC BRAIN INJURYJul 24, 15Jan 28, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9752180 Methods and compositions for amplification and detection of MicroRNAsNov 11, 13Sep 05, 17[C12Q, C12P, C12N]
9737587 Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide mimeticNov 24, 15Aug 22, 17[A61K, A01N]
9603905 Intranasal insulin administration for the minimization of anesthesia-induced memory lossMar 13, 15Mar 28, 17[A61K]
9512178 Neurogenic brain-derived neurotrophic factor peptidesJul 11, 13Dec 06, 16[A61K, C07K]
9429583 System and method for quantifying fragile X mental retardiation 1 protein in tissue and blood samplesJan 13, 14Aug 30, 16[G01N]
9327011 Neurotrophic peptides for the treatment of tauopathiesAug 21, 14May 03, 16[A61K, C07K]
9265735 Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereofNov 30, 11Feb 23, 16[A61K, C12Q]
9249203 Treatment of brain injury with a neurotrophic peptideJul 08, 14Feb 02, 16[A61K, A01N, C07K]
9115400 gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisSep 12, 13Aug 25, 15[C07H, C12Q, C07K]
8796214 Neurotrophic peptidesNov 12, 12Aug 05, 14[A61K, A01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0114,410 SYSTEM AND METHOD FOR DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERSAbandonedOct 24, 16Apr 27, 17[A61K, C12Q, G01N]
2016/0002,307 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSISAbandonedJul 14, 15Jan 07, 16[C07K]
2014/0056,998 SYSTEM AND METHOD FOR DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERSAbandonedNov 01, 13Feb 27, 14[A61K, C12Q]
8535884 gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisExpiredSep 09, 11Sep 17, 13[C07H, C12Q]
8257942 Tissue embedding matrixExpiredJul 10, 07Sep 04, 12[C12Q]
2012/0114,767 System and Method for Diagnosis and Treatment of Neuropsychiatric DisordersAbandonedDec 12, 11May 10, 12[A61K, C12Q, A61P]
2008/0070,263 Method for Differentiation of Alzheimer's Disease into SubgroupsAbandonedAug 14, 07Mar 20, 08[G01N]
7256003 Method for differentiation of Alzheimer's Disease into subgroupsExpiredJul 13, 04Aug 14, 07[G01N]
2007/0105,105 Surrogate cell gene expression signatures for evaluating the physical state of a subjectAbandonedMay 24, 04May 10, 07[C12Q, C12P]
7090987 Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementiaExpiredApr 28, 00Aug 15, 06[C12Q]
2005/0227,941 Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseasesAbandonedMay 24, 05Oct 13, 05[A61K, G01N]
2005/0172,344 Cell cultures from animal models of Alzheimer's disease for screening and testing drug efficacyAbandonedNov 03, 04Aug 04, 05[C12N, A01K]
2004/0253,647 Cell-based high-throughput screening methodsAbandonedAug 06, 04Dec 16, 04[G01N]
2003/0186,237 Methods and compositions of amplifying RNAAbandonedFeb 14, 02Oct 02, 03[C12Q, C12P]
2002/0183,390 D-serine transport antagonist for treating psychosisAbandonedFeb 06, 02Dec 05, 02[A61K]
5919823 Treatment of secondary movement disorders using large neutral amino acidsExpiredMay 09, 97Jul 06, 99[A61K]
5670539 Treatment of movement disorders using large neutral amino acidsExpiredJan 11, 95Sep 23, 97[A61K]
4806627 Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteinsExpiredMay 29, 87Feb 21, 89[A61K, C07K]
4783456 Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smokingExpiredJun 12, 87Nov 08, 88[A61K]
4683231 Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smokingExpiredApr 16, 86Jul 28, 87[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.